Larry Ramer

Larry Ramer

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

The $30 Billion Reason Seagen (SGEN) Stock Is Up 11% Today

SGEN stock is climbing about 11% in early trading. Pfizer is reportedly interested in buying the biotech for its line of cancer treatments.

7 Penny Stocks to Buy and Hold for the Next Decade

These penny stocks to buy and hold with great products, huge markets, and partnerships can become the large-cap stocks of tomorrow.

Why ObsEva (OBSV) Stock Is Down 36% Today

ObsEva (OBSV), a Swiss drug maker, is trending on social media, and OBSV stock is tumbling 36% to 10.85 cents. 

3 Surging Stocks That the Big Money Loves

Investors who are looking for stocks to buy should keep in mind that instructions still have an outsized influence on stock prices.

3 Undervalued Consumer Stocks to Buy in February

The results of several large companies show that American middle-class and wealthy consumers are in good shape, making this a good time to find undervalued consumer stocks to buy.